At the news
? BEARISHIMPACT 6/10 424B5 filed Nov 16, 2026 at 07:00 ET
InspireMD priced a $37.5M underwritten offering of 7.3M shares, pre-funded warrants for 50.4M shares, and Series L warrants for 43.3M shares at $0.65 per unit. The offering follows the recent FDA approval of CGuard Prime 80 cm for TCAR procedures and the company's disclosure of preliminary Q3 2026 revenue of $2.2M and cash of $19.2M. Proceeds will fund operations, R&D, and working capital. The offering is highly dilutive relative to the current 46.8M shares outstanding.
- Total offering size of $37,494,965 (7,342,308 shares at $0.65, pre-funded warrants for 50,350,000 shares at $0.6499, and Series L warrants for 43,269,231 shares at $0.65)
- Net proceeds to company expected to be approximately $34.9 million
- Offering priced at $0.65 per share, a 16% discount to the last reported sale price of $0.774 on November 12, 2026
- Shares outstanding after offering: 54,127,439 (assuming no exercise of warrants or over-allotment), up from 46,785,131 as of November 12, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access